Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen C Nelson

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Oncogene|December 5, 2018
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Cell Reports|February 10, 2021
Apocryphal FADS2 activity promotes fatty acid diversification in cancerReuben S E Young, Andrew P Bowman, Elizabeth D Williams, et al.
Oncogene|September 9, 2018
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
The Prostate|February 22, 2023
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancerMark N Adams, Laura V Croft, Aaron Urquhart, et al.
The Journal of Pathology|February 20, 2015
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentQian Wang, Rae-Anne Hardie, Andrew J Hoy, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Oncogene|December 5, 2018
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Cell Reports|February 10, 2021
Apocryphal FADS2 activity promotes fatty acid diversification in cancerReuben S E Young, Andrew P Bowman, Elizabeth D Williams, et al.
Oncogene|September 9, 2018
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
The Prostate|February 22, 2023
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancerMark N Adams, Laura V Croft, Aaron Urquhart, et al.
The Journal of Pathology|February 20, 2015
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentQian Wang, Rae-Anne Hardie, Andrew J Hoy, et al.
Pageof 12